BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36511264)

  • 1. Evaluation of Survival Rate and Associated Factors in Patients with Cervical Cancer: A Retrospective Cohort Study.
    Tabatabaei FS; Saeedian A; Azimi A; Kolahdouzan K; Esmati E; Maddah Safaei A
    J Res Health Sci; 2022 Jun; 22(2):e00552. PubMed ID: 36511264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia.
    Anfinan N; Sait K
    Ann Saudi Med; 2020; 40(1):25-35. PubMed ID: 32026705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer.
    Yin Z; Lou H; Tang H; Ni J; Zhou Q; Chen M
    Radiat Oncol; 2019 May; 14(1):82. PubMed ID: 31109371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
    Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
    Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer.
    Chen W; Xiu S; Xie X; Guo H; Xu Y; Bai P; Xia X
    Radiat Oncol; 2022 Jan; 17(1):6. PubMed ID: 35012582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer.
    Hanprasertpong J; Jiamset I; Geater A; Leetanaporn K; Peerawong T
    J Gynecol Oncol; 2017 Jul; 28(4):e42. PubMed ID: 28541633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma.
    Aslan K; Haberal A; Akıllı H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2021 Nov; 304(5):1279-1289. PubMed ID: 33772630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
    Queiroz ACM; Fabri V; Mantoan H; Sanches SM; Guimarães APG; Ribeiro ARG; da Nogueira Silveira Lima JP; Chen MJ; Baiocchi G; da Costa AABA
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():6-12. PubMed ID: 30771718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment Mean Apparent Diffusion Coefficient Is Significantly Correlated With Event-Free Survival in Patients With International Federation of Gynecology and Obstetrics Stage Ib to IIIb Cervical Cancer.
    Himoto Y; Fujimoto K; Kido A; Baba T; Tanaka S; Morisawa N; Koyasu S; Konishi I; Togashi K
    Int J Gynecol Cancer; 2015 Jul; 25(6):1079-85. PubMed ID: 25853385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
    Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
    Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
    Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
    Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 17. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
    Binbin T; Lingying W; Manni H; Jusheng A; Ning L
    Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix.
    Kim JH; Shim SH; Nam SH; Lee SW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT
    J Minim Invasive Gynecol; 2020; 27(7):1558-1565. PubMed ID: 32084588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
    Hu K; Wang W; Liu X; Meng Q; Zhang F
    Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.